About Vineet Life Sciences Limited
Data last updated: 22 December 2025
Vineet Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 21 January 2014, the company has been in operation for over 12 years.
Registered with ROC Hyderabad under CIN U24211TG2014PLC092453.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹9.93 Cr. Formerly known as Vineet Life Sciences Private Limited. It is led by directors including Gaddam Venkata Ramana and Satyanarayana Raju Bhupathiraju.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: H.No.3 – 15 – 72/B4/26 Bahar – B Sahara States Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500070.
As per the financials filed for FY 2024, the company reported a revenue of ₹101.85 Cr, a growth of 48% compared to the previous year.
The company has a workforce of approximately 38 employees as per the latest available data.
The company is associated with 1 brand - Vineet Life Sciences. As per MCA filings, the company has open charges of ₹26.7 Cr and satisfied charges of ₹17.85 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vineetlife.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressH.No.3 – 15 – 72/B4/26 Bahar – B Sahara States Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500070
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vineet Life Sciences Limited
Vineet Life Sciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24211TG2014PLC092453, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24211TG2014PLC092453 | Current |
| U24211AP2014PTC092453 | Previous |
| U24211TG2014PTC092453 | Previous |
Associated Brands with Vineet Life Sciences Limited
Vineet Life Sciences Limited operates one associated brand: Vineet Life Sciences. These brands represent Vineet Life Sciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures intermediates for active pharmaceutical ingredients and fine chemicals. | vineetlife.in |
Competitors & Alternatives of Vineet Life Sciences Limited
Brands and companies operating in the same space as Vineet Life Sciences Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Inventys
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
Viyash
|
APIs and intermediates are manufactured by Viyash as a CDMO. | Hyderabad, India, India | 2019 |
Blue Jet Healthcare
|
CDMO focused on manufacturing, supplier, and development of intermediates & APIs | Mumbai, India, India | 1969 |
Ami organics
|
Advanced API intermediates are manufactured for pharmaceutical use. | Surat, India, India | 2007 |
Aparna Pharmaceuticals
|
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | Hyderabad, India, India | 2008 |
HuiSheng Biotech Pharmaceutical
|
APIs, intermediates, and finished dosage forms are manufactured. | Hangzhou, China, China | 2004 |
DUDE CHEM
|
CDMO focused on manufacturing of APIs and intermediates | Berlin, Germany, Germany | 2019 |
Enanti Labs
|
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | Hyderabad, India, India | 2007 |
Hindys Lab
|
Manufactures and exports pharmaceutical intermediates for global markets. | Hyderabad, India, India | 2007 |
Business Activity of Vineet Life Sciences Limited
Vineet Life Sciences Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Vineet Life Sciences Limited
Vineet Life Sciences Limited is currently managed by 4 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Gaddam Venkata Ramana
Also directs:
Vineet Laboratories Limited, Vineet Chem Trade Private Limited, Wohler Laboratories Private Limited and 2 more
|
Managing Director | 21 Jan 2014 | 12 Years 5 Months | Current |
|
Satyanarayana Raju Bhupathiraju
Also directs:
Vineet Laboratories Limited, Vineet Life Sciences Limited
|
Director | 29 Nov 2018 | 7 Years 7 Months | Current |
| Kandula Murali Mohan | Director | 21 Jan 2014 | 12 Years 5 Months | Current |
|
Varaprasada Rao Valluru
Also directs:
Vineet Life Sciences Limited, Satyadeva Organosys Private Limited
|
Director | 18 Apr 2015 | 11 Years 2 Months | Current |
Financials of Vineet Life Sciences Limited FY 2024 filings available
Vineet Life Sciences Limited reported revenue of ₹101.85 Cr (up 48% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Vineet Life Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2024 | Hdfc Bank Limited | ₹26.7 Cr | Open |
| 28 Oct 2019 | State Bank of India | ₹17.85 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Vineet Life Sciences Limited
View historical data on people associated with Vineet Life Sciences Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Vineet Life Sciences Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vineet Life Sciences Limited
GSTIN & GST Filing Data of Vineet Life Sciences Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vineet Life Sciences Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vineet Life Sciences Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vineet Life Sciences Limited
MSME Payment Delays by Vineet Life Sciences Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vineet Life Sciences Limited
Subsidiaries & Group Companies of Vineet Life Sciences Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vineet Life Sciences Limited with ownership details.
MCA Filings & Documents of Vineet Life Sciences Limited
MCA Filings & Documents of Vineet Life Sciences Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vineet Life Sciences Limited
Frequently Asked Questions about Vineet Life Sciences Limited
Vineet Life Sciences Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 21 January 2014 (12+ years old) and is registered under CIN U24211TG2014PLC092453. The company has 38 employees.
Vineet Life Sciences Limited reported revenue of ₹101.85 Cr for FY 2024 (up 48.00% YoY).
The current directors of Vineet Life Sciences Limited are:
The primary industry of Vineet Life Sciences Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Vineet Life Sciences Limited can be reached at the registered office: H.No.3 – 15 – 72B426 Bahar – B Sahara States Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500070, or through the website vineetlife.in.
The authorised capital is ₹25 Cr, and the paid-up capital is ₹9.93 Cr.